International Wex Technologies (WXI): Pivotal Phase IIb/III Trial Of Tectin(TM) For Cancer Pain Begins
10/19/2005 5:11:12 PM
Investigators involved in the pivotal clinical trial of Tectin(TM) enrolled and dosed the first of up to 150 patients that will participate in the study. It is one of the largest Canadian clinical trials to evaluate the efficacy and safety of a drug for treatment of medically refractory cancer pain, and will take place in up to 25 treatment centres across Canada.
comments powered by